GROENEWEGEN A , RUTTEN FH , MOSTERD A , et al . Epidemiology of heart failure [J]. Eur J Heart Fail , 2020 , 22 ( 8 ): 1342 - 1356 .
ARMSTRONG PW , PIESKE B , ANSTROM KJ , et al . Vericiguat in patients with heart failure and reduced ejection fraction [J]. N Engl J Med , 2020 , 382 ( 20 ): 1883 - 1893 .
PITT B , BHATT DL , SZAREK M , et al . Effect of sotagliflozin on early mortality and heart failure-related events: a post hoc analysis of SOLOIST-WHF [J]. JACC Heart Fail , 2023 , 11 ( 8 Pt 1 ): 879 - 889 .
LEE DC , JOHNSON RA , BINGHAM JB , et al . Heart failure in outpatients: a randomized trial of digoxin versus placebo [J]. N Engl J Med , 1982 , 306 ( 12 ): 699 - 705 .
ABRAHAM WT , PONIKOWSKI P , BRUECKMANN M , et al . Rationale and design of the EMPERIAL-Preserved and EMPERIAL-Reduced trials of empagliflozin in patients with chronic heart failure [J]. Eur J Heart Fail , 2019 , 21 ( 7 ): 932 - 942 .
AMBROSY AP , PANG PS , KHAN S , et al . Clinical course and predictive value of congestion during hospita-lization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial [J]. Eur Heart J , 2013 , 34 ( 11 ): 835 - 843 .
SOLOMON SD , MCMURRAY JJV , ANAND IS , et al . Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction [J]. N Engl J Med , 2019 , 381 ( 17 ): 1609 - 1620 .
BUTLER J , KHAN MS , MORI C , et al . Minimal clinically important difference in quality of life scores for patients with heart failure and reduced ejection fraction [J]. Eur J Heart Fail , 2020 , 22 ( 6 ): 999 - 1005 .
INFELD M , WAHLBERG K , CICERO J , et al . Effect of personalized accelerated pacing on quality of life, physical activity, and atrial fibrillation in patients with preclinical and overt heart failure with preserved ejection fraction:the myPACE randomized clinical trial [J]. JAMA Cardiol , 2023 , 8 ( 3 ): 213 - 221 .
VAN SPALL HGC , LEE SF , XIE F , et al . Effect of patient-centered transitional care services on clinical outcomes in patients hospitalized for heart failure: the PACT-HF randomized clinical trial [J]. JAMA , 2019 , 321 ( 8 ): 753 - 761 .
WARE JE , SHERBOURNE CD . The mos 36-item short-form health survey (SF-36):I. conceptual framework and item selection [J]. Med Care , 1992 , 30 ( 6 ): 473 - 483 .
THE WHOQOL Group . The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization [J]. Soc Sci Med , 1995 , 41 ( 10 ): 1403 - 1409 .
HUNT SM , MCKENNA SP , MCEWEN J , et al . The Nottingham Health Profile: subjective health status and medical consultations [J]. Soc Sci Med A , 1981 , 15 ( 3 Pt 1 ): 221 - 229 .
YANCY CW , JESSUP M , BOZKURT B , et al . 2013 ACCF/AHA guideline for the management of heart fai-lure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines [J]. Circulation , 2013 , 128 ( 16 ): e240-327 .
SAVARESE G , STOLFO D , SINAGRA G , et al . Heart failure with mid-range or mildly reduced ejection fraction [J]. Nat Rev Cardiol , 2022 , 19 ( 2 ): 100 - 116 .
OIKONOMOU EK , KOKKINIDIS DG , KAMPAKTSIS PN , et al . Assessment of prognostic value of left ventricular global longitudinal strain for early prediction of chemotherapy-induced cardiotoxicity: a systematic review and meta-analysis [J]. JAMA Cardiol , 2019 , 4 ( 10 ): 1007 - 1018 .
HEIDENREICH PA , BOZKURT B , AGUILAR D , et al . 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [J]. Circulation , 2022 , 145 ( 18 ): e876 - e894 .
ZANNAD F , GARCIA AA , ANKER SD , et al . Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document [J]. Eur J Heart Fail , 2013 , 15 ( 10 ): 1082 - 1094 .
LI Guolie's Experience in Treating Orthostatic Hypotension from the Perspective of "Raising the Clear and Directing the Turbid Downward"
Efficacy and Economic Evaluation of Weishi Qingjin Formula (苇石清金方)in the Treatment of Adult Community-Acquired Pneumonia with Phlegm-Heat Obstructing the Lung Syndrome:A Multicenter Retrospective Real-World Cohort Study
Similarities and Differences between Myofascial Trigger Points and Sinew Knot:from the Perspective of the Channel Sinew Theory
A Preliminary Discussion on the Method of Regulating Qi and Calming the Mind
Challenges and Recommendations for Implementing Key Technologies in Decentralized Clinical Trials of Traditional Chinese Medicine